Product Details:
Dose/Strength | 400mg, 100mg |
Composition | Sofosbuvir and Velpatasvir Tablets |
Brand | Resof |
Pack Size | 28 tablets |
Manufactured by | Dr. Reddys |
Product Details:
Manufacturer | Natco |
Composition | Sofosbuvir Plus Velpatasvir Tablets |
Brand | Velpanat |
Pack Size | 28 tablets |
Manufactured by | Natco |
Dose | 400mg, 100mg |
Product Details:
Minimum Order Quantity | 1 Bottle |
Pack size | 28 Tab |
Composition | sofosbuvir 400 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Sofocure |
Manufacturer | Emcure |
Form | Tablet |
Shelf life | 2021 |
Additional Information:
Product Details:
Manufacturer | Abbott |
Treatment | HEP C |
Prescription/Non prescription | Prescription |
Dose/Strength | 90 mg, 400 mg |
Composition | Ledipasvir and Sofosbuvir Tablets |
Brand | Ledviclear |
Pack Size | 1x28 tablets |
Manufactured by | Abbott |
Product Details:
Manufacturer | Hetero |
Dose/Strength | 400 mg |
Composition | Sofosbuvir Tablets |
Brand | Sofovir |
Pack Size | 28 tablets |
Manufactured by | Hetero |
Product Details:
Pack size | 28 Tab |
Brand | Hepcinat |
Manufacturer | Natco |
Composition | Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Form | Tablet |
Shelf life | 2021 |
Product Details:
Packaging Size | 28 TABLETS |
Strength | 400MG + 90MG |
Composition | SOFOSBUVIR + LEDIPASVIR |
Treatment | HCV |
Prescription/Non prescription | Prescription |
Brand | EMCURE |
Manufacturer | EMCURE |
Form | Tablet |
Product Details:
Minimum Order Quantity | 2 Packet |
Manufacturer | Emcure |
Treatment | HEP C |
Prescription/Non prescription | Prescription |
Dose/Strength | 60 mg |
Composition | Daclatasvir Dihydrochloride Tablets |
Form | Tablet |
Brand | Daclacure |
Pack Size | 28 tablets |
Manufactured by | Emcure |
Product Details:
Minimum Order Quantity | 1 bottle |
Manufacturer | Cadila Healthcare Ltd (Zydus) |
Composition | Velpatasvir (100 mg) + Sofosbuvir (400 mg) |
Treatment | hepatitis C infection. |
Dose/Strength | 400 mg,100 mg |
Brand | Sovihep V |
Manufactured by | Zydus Heptiza |
Additional Information:
Product Details:
Minimum Order Quantity | 1 Bottle |
Pack size | 28 Tab |
Composition | Daclatasvir 60 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Daclacure |
Manufacturer | Emcure |
Form | Tablet |
Shelf life | 2021 |
Additional Information:
Product Details:
Minimum Order Quantity | 1 Bottle |
Pack size | 60 TABS |
Manufacturer | DR REDDY |
Treatment | HEPATITIS C |
Prescription/Non prescription | Prescription |
Dose/Strength | 60 mg |
Composition | Daclatasvir Tablets |
Brand | Hepcfix-60 |
Manufactured by | Dr-Reddys |
Product Details:
Minimum Order Quantity | 1 Bottle |
Pack size | 28 tablets |
Manufacturer | Hetero |
Treatment | Hep c |
Prescription/Non prescription | Prescription |
Dose/Strength | 60 mg |
Composition | Daclatasvir Tablets |
Brand | Daclahep |
Manufactured by | Hetero |
Common Side Effects of Daclatasvir:
Additional Information:
Product Details:
Minimum Order Quantity | 1 Bottle |
Pack size | 28 tablets |
Manufacturer | Cadila Healthcare Ltd (Zydus) |
Composition | Daclatasvir |
Brand | zydus heptiza |
Treatment | HEP C |
Prescription/Non prescription | Prescription |
Packaging Type | 28 tablet |
Product Details:
Minimum Order Quantity | 1 Bottle |
Pack size | 28 Tab |
Brand | Hepcinat Lp |
Manufacturer | Natco |
Composition | Ledipasvir 90 mg & Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Packaging Size | 28 |
Packaging Type | Bottle |
Form | Tablet |
Dosage Form | Tablet |
Hepcinat-Lp Tablet helps in the treatment of chronic hepatitis C (HCV). This drug is used in a combination with another drug, to prevent the spread of HCV throughout the body.
Patients who have liver issues, or kidney problems and are undergoing dialysis, are not advised the use of Hepcinat-Lp Tablet. Also inform your doctor about any other health issues you are suffering from and if you are taking any medicines to treat them.
Hepcinat-Lp Tablet is meant to be taken orally, either with food or without. Antacids containing magnesium or aluminum should not be consumed for a few hours after taking the drug. The drug should be taken regularly, preferably at a particular time each day. Try not to miss any doses.
Hepcinat-Lp Tablet may result in a few common side effects such as irritation, pain in the muscles, diarrhea, headache, cough, and problems with sleep. Side effects that are less common but may occur none the less are loss of appetite, discontentment, dizziness and problems with concentration. If these side effects persist or deteriorate, get in touch with your health care provider immediately.
In case of adults, 1 tablet is prescribed to be taken every day for about 12 weeks.
Information given here is based on the salt and content of the medicine. Effect and uses of medicine may vary from person to person. It is advicable to consult a Hepatologist before using this medicine.
What are the side effects of Hepcinat-Lp Tablet ?Product Details:
Minimum Order Quantity | 1 Bottle |
Pack size | 28 Tab |
Brand | Ledifos |
Packaging Size | 28 |
Form | Tablet |
Dosage Form | Tablet |
Prescription/Non prescription | Prescription |
Packaging Type | Bottle |
Treatment | Hepatitis C |
Composition | Ledipasvir 90 mg & sofosbuvir 400 mg |
Product Details:
Strength | Sofosbuvir 400 mg & Daclatasvir 60 mg |
Packaging size | 28 Tab |
Brand | Sovihep D |
Composition | Sofosbuvir 400 mg & Daclatasvir 60 mg |
Manufacturer | Cadila Healthcare (Zydus) |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Form | Tablet |
Shelf life | 2020 |
Sovihep D drug is a mix of Sofosbuvir and Daclatasvir. Sovihep D Tablet is utilized in a blend with different drugs, for example, ribavirin, daclatasvir, and peginterferon to treat unending hepatitis C. It works by decreasing the hepatitis C infection in the body. This keeps liver issue, for example, cirrhosis and liver disease under control.
Hepatitis C is an irresistible malady influencing basically the liver, caused by the Hepatitis C Virus (HCV). It spreads basically through blood-to-blood contact related with inadequately sanitized therapeutic hardware, and transfusions. An expected 150 200 million individuals worldwide are contaminated with hepatitis C.
The disease is regularly asymptomatic; however chronic contamination can prompt scarring of the liver and cirrhosis. A few patients may likewise create liver disappointment, liver disease, or perilous confusions. The individuals who create cirrhosis or liver malignant growth may require a liver transplant. Hepatitis C is the main purpose behind liver transplantation, however the infection more often than not repeats after transplantation.
What is it endorsed for?
What are the side-effects of Sovihep D tablet?
Apart from its expected impact, Sovihep D Tablet may cause some undesirable impacts as well. In such cases, you should look for therapeutic consideration quickly. This isn’t a comprehensive rundown of reactions. It would be ideal if you tell your specialist in case you encounter any allergic response to the prescription such as;
Call your specialist without a moment’s delay in the event that you have:
Medication Interactions of Sovihep D tablet:
In the event that You Have: Liver Problems Other Than Hepatitis C Infection; Had A Liver Transplant; Severe Kidney Problems Or Are On Dialysis; HIV; Any Other Medical Condition; Or If You Are Breastfeeding Or Plan To Breastfeed. You And Your Healthcare Provider Should Decide If You Will Take Sofosbuvir Or Breastfeed. You Should Not Do Both. In the event that you take Amiodarone Tell Your Healthcare Provider about All the Medicines You Take, Including Prescription and Over-The-Counter Medicines, Vitamins, And Herbal Supplements. Different Medicines May Affect How Sofosbuvir Works.
Product Details:
Packaging Size | 28 Tab |
Strength | 460 mg |
Composition | Sofosbuvir 400 mg,Daclatasvir 60 mg |
Treatment | Hepatitis C |
Brand | Sofokast plus |
Manufacturer | Aprazer |
Form | Tablet |
Sofokast plus tablets, which contain 400 mg Sofosbuvir is a nucleotide polymerase inhibitor, and includes antiviral drugs direct action. sofosbuvir is exposed to have a high barrier to growth resistance and inhibits the Cb NS5B Hep protein. Thus, Sofosbuvir interferes with the enzyme RNA polymerase by a cell worker who can perform the reproduction process. Consequently, Sofosbuvir stops hepatitis C virus replication and reduces the amount of Hep C virus in the liver. Sofosbuvir also acts to reduce liver damage and improve liver function.
Sofokast plus tablets also contains daclatasvir, a direct-acting antiviral drug that is indicated for a patient affected by hepatitis C virus infection. It will target the Hep C virus and stops numerous steps in the HCV reproduction process by preventing viral particles from making copies themselves, and helps the body remove the virus from the blood.
Absorption: –Peak plasma concentration is 0. 5-2 h after dose for 40% Sofosbuvir and in metabolite GS-331007 peak plasma concentration obtained 2-4 hours after administration where, as in Daclatasvir, peak plasma plasma concentration is within 2 hours after dose administration and bioavailability is 67%
Food effect:Sofosbuvir 400 mg and metabolite do not affect fatty flour. Hence, Sofosbuvir is managed without food. In Daclatasvir, 60 mg of the drug was not taken with or without food.
Distribution:Sofosbuvir 400 mg is about 51-65% bound to human plasma proteins, and the metabolite GS-331007 has minimal binding to human plasma proteins. And in Daclatasvir 60 mg protein binding protein is 99%
Metabolism:In the liver, Sofosbuvir 400 mg is extensively metabolized (4% and> 90%) to be converted into the pharmacologically active nucleoside analog of GS – 461203 triphosphate. Daclatasvir 60 mg metabolism based on CYP3A substrate with initial CYP isoform.
Elimination:The average total recovery dose of 400 mg Sofosbuvir was> 92% and included removal of 80%, 14% and 2, 5% in urine, feces, exhaled air. After a single dose Daclatasvir 60 mg radioactivity recovered to 88% via the faeces and 6, 6% through urine
Half the life of Sofosbuvir 400 mg and GS-331007 was 0, 4 and 27 hours, and Daclatasvir 60 mg had a half-life of 12 to 15 hours
Product Details:
Packaging Size | 120 MCG |
Manufacturer | ZYDUS CADILA |
Treatment | HCV |
Prescription/Non prescription | Prescription |
Form | Injection |
Usage/Application | Clinical |
Composition | PEGYLATED INTERFERON ALPHA 2B 120MCG |
Injectable Form | Liquid |
Dose | 120 MCG |
Medicine Type | Injection |
Product Details:
Composition | Daclatasvir Tablets |
Brand | Hepcdac |
Pack Size | 28 tablets |
Manufactured by | Cipla |
Product Details:
Brand | cipla |
Composition | sofosbuvir 400mg |
Packaging Size | 15 TABLETS |
Dose/Strength | 400mg |
Dosage Form | Tablet |
Usage/Application | Personal |
Dosage Form | Tablet |
Dose/Strength | 400mg |
Packaging Size | Pack of 28 Tablet |
Additional Information:
Product Details:
Brand | Hepcvir L |
Composition | Sofosbuvir 400 mg & Ledipasvir 90 mg |
Packaging Size | 28 Tab |
Dose/Strength | Sofosbuvir 400 mg & Ledipasvir 90 mg |
Usage/Application | Clinical |
Packaging Type | Bottle |
Manufactured By | Cipla |
Product Details:
Dose/Strength | 60 mg |
Composition | Daclatasvir Dihydrochloride Tablets |
Pack Size | 28 tablets |
Manufactured by | Natdac 60 |
Product Details:
Minimum Order Quantity | 1 Bottle |
Pack size | 30 TABLETS |
Manufacturer | Cadila Healthcare Ltd (Zydus) |
Composition | Ledipasvir (90mg) + Sofosbuvir (400mg) |
Brand | ZYDUS HEPTIZA |
Treatment | HEPATITIS C |
Prescription/Non prescription | Prescription |
Packaging Size | 30 TABS |
Form | Tablet |
Dosage Form | Tablet |
Additional Information: